Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Anna Balato, Emanuele Scala, Nicola Balato, Giuseppina Caiazzo, Roberta Di Caprio, Giuseppe Monfrecola, Annunziata Raimondo, Serena Lembo & Fabio Ayala. (2017) Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders. Expert Opinion on Biological Therapy 17:11, pages 1363-1374.
Read now
Read now
Renata Baronaite Hansen & Arthur Kavanaugh. (2014) Treatment options for psoriatic arthritis. Expert Opinion on Orphan Drugs 2:7, pages 695-708.
Read now
Read now
Sowmya Varada, Suzanne J Tintle & Alice B Gottlieb. (2014) Apremilast for the treatment of psoriatic arthritis. Expert Review of Clinical Pharmacology 7:3, pages 239-250.
Read now
Read now
M de la Brassinne, V Failla & AF Nikkels. (2013) PSORIASIS: STATE OF THE ART 2013. Acta Clinica Belgica 68:6, pages 427-432.
Read now
Read now
Brandon Shutty, Cameron West, Megan Pellerin & Steven Feldman. (2012)
Apremilast as a treatment for psoriasis. Expert Opinion on Pharmacotherapy 13:12, pages 1761-1770.
Read now
Read now
Articles from other publishers (26)
Farhad Babaie, Melodi Omraninava, Armita Mahdavi Gorabi, Arezou Khosrojerdi, Saeed Aslani, Arsalan Yazdchi, Shahram Torkamandi, Haleh Mikaeili, Thozhukat Sathyapalan & Amirhossein Sahebkar. (2022) Etiopathogenesis of Psoriasis from Genetic Perspective: An updated
Review. Current Genomics 23:3, pages 163-174.
Crossref
Crossref
Monu Yadav, Ishu Sardana, Amarjeet Sharma, Nidhi Sharma, Kalpana Nagpal & Paramjeet Malik. (2020) Emerging Pathophysiological Targets of Psoriasis for Future Therapeutic Strategies. Infectious Disorders - Drug Targets 20:4, pages 409-422.
Crossref
Crossref
Janet Roberts, Darren D O'Rielly & Proton Rahman. (2018) A review of ustekinumab in the treatment of psoriatic arthritis. Immunotherapy 10:5, pages 361-372.
Crossref
Crossref
Charlotte Thompson, Ruth Davies & Ernest Choy. (2016) Anti cytokine therapy in chronic inflammatory arthritis. Cytokine 86, pages 92-99.
Crossref
Crossref
Guo-Bo Li, Shuang Ma, Ling-Ling Yang, Sen Ji, Zhen Fang, Guo Zhang, Li-Jiao Wang, Jie-Min Zhong, Yu Xiong, Jiang-Hong Wang, Shen-Zhen Huang, Lin-Li Li, Rong Xiang, Dawen Niu, Ying-Chun Chen & Sheng-Yong Yang. (2016)
Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1
H
-Pyrazolo[3,4-
d
]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(
tert
-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model
. Journal of Medicinal Chemistry 59:18, pages 8293-8305.
Crossref
Crossref
Clara De Simone, Francesca Perino, Giacomo Caldarola, Magda D’Agostino & Ketty Peris. (2016) Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports. Journal of International Medical Research 44:1_suppl, pages 67-71.
Crossref
Crossref
Darren D. O’Rielly & Proton Rahman. (2015) Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis. Rheumatic Disease Clinics of North America 41:4, pages 623-642.
Crossref
Crossref
Marina Papoutsaki & Christina Antoniou. 2015. European Handbook of Dermatological Treatments. European Handbook of Dermatological Treatments
1411
1420
.
Caitriona Ryan & Alan Menter. 2014. Psoriasis. Psoriasis
249
267
.
Matthew K. Sandre & Sherry Rohekar. (2014) Psoriatic arthritis and nail changes: Exploring the relationship. Seminars in Arthritis and Rheumatism 44:2, pages 162-169.
Crossref
Crossref
Darren D. O'Rielly & Proton Rahman. (2014) Genetics of psoriatic arthritis. Best Practice & Research Clinical Rheumatology 28:5, pages 673-685.
Crossref
Crossref
Ia KhmaladzeTiina Kelkka, Simon GuerardKajsa WingAngela PizzollaAmit SaxenaKatarina Lundqvist, Meirav Holmdahl, Kutty Selva NandakumarRikard Holmdahl. (2014) Mannan induces ROS-regulated, IL-17A–dependent psoriasis arthritis-like disease in mice. Proceedings of the National Academy of Sciences 111:35.
Crossref
Crossref
Jie Wang, Yow-Ming C. Wang & Hae-Young Ahn. (2014) Biological Products for the Treatment of Psoriasis: Therapeutic Targets, Pharmacodynamics and Disease-Drug-Drug Interaction Implications. The AAPS Journal 16:5, pages 938-947.
Crossref
Crossref
Renata Baronaite Hansen & Arthur Kavanaugh. (2014) Novel Treatments with Small Molecules in Psoriatic Arthritis. Current Rheumatology Reports 16:9.
Crossref
Crossref
Caitriona Ryan, Neil J. Korman, Joel M. Gelfand, Henry W. Lim, Craig A. Elmets, Steven R. Feldman, Alice B. Gottlieb, John Y.M. Koo, Mark Lebwohl, Craig L. Leonardi, Abby S. Van Voorhees, Reva Bhushan & Alan Menter. (2014) Research gaps in psoriasis: Opportunities for future studies. Journal of the American Academy of Dermatology 70:1, pages 146-167.
Crossref
Crossref
B. Zhu, E. Edson-Heredia, G.S. Cameron, W. Shen, J. Erickson, D. Shrom, P. Wang, S. Banerjee & K.B. Gordon. (2013) Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis. British Journal of Dermatology 169:6, pages 1337-1341.
Crossref
Crossref
B. Mansouri, M. Patel & A. Menter. (2013) Tumour necrosis factor-α inhibitor use in patients with psoriasis with organ transplantation. British Journal of Dermatology 169:2, pages 481-483.
Crossref
Crossref
Darren D. O’Rielly & Proton Rahman. (2013) Advances in the Genetics of Spondyloarthritis and Clinical Implications. Current Rheumatology Reports 15:8.
Crossref
Crossref
Wing Lau, Charles Heard & Alex White. (2013) Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis. Pharmaceutics 5:4, pages 232-245.
Crossref
Crossref
Kuntal Ghosh, Gunjan Sharma, Amrita Saha, Susanta Kar, Pijush K. Das & Anindita Ukil. (2013) Successful Therapy of Visceral Leishmaniasis With Curdlan Involves T-Helper 17 Cytokines. The Journal of Infectious Diseases 207:6, pages 1016-1025.
Crossref
Crossref
Luis A. Zúñiga, Renu Jain, Christopher Haines & Daniel J. Cua. (2013) Th17 cell development: from the cradle to the grave. Immunological Reviews 252:1, pages 78-88.
Crossref
Crossref
. (2013) Current World Literature. Current Opinion in Rheumatology 25:2, pages 275-283.
Crossref
Crossref
Sarah Dubois Declercq & Roxane Pouliot. (2013) Promising New Treatments for Psoriasis. The Scientific World Journal 2013, pages 1-9.
Crossref
Crossref
Peter Lloyd, Caitriona Ryan & Alan Menter. (2012) Psoriatic Arthritis: An Update. Arthritis 2012, pages 1-6.
Crossref
Crossref
Tiziana Lepre, Stefania Zampatti, Giuseppe Novelli & Emiliano Giardina. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Philippe Carron, Liesbet Van Praet, Peggy Jacques, Dirk Elewaut & Filip Van den Bosch. (2012) Therapy for Spondyloarthritis. Rheumatic Disease Clinics of North America 38:3, pages 583-600.
Crossref
Crossref